Skip to Content

WPI 3630 (Hydromorphone Hydrochloride Extended-Release 16 mg)

Pill with imprint WPI 3630 is Yellow, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 16 mg. It is supplied by Watson Laboratories, Inc..

Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 16 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3630

Hydromorphone Hydrochloride Extended-Release

Imprint
WPI 3630
Strength
16 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3630

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.